Mycoses
Latest News
FDA passes on olorofim despite critical need for antifungals
There are only four antifungal classes currently available, and there are few new candidates in the pipeline.
Livin' on the MDedge
Pound of flesh buys less prison time
Plus: Organ donation for fun and profit, and parasite expulsion with a blast of fat.
Feature
Rise of the fungi: Pandemic tied to increasing fungal infections
COVID-19 has lifted the lid on the risks of secondary pulmonary fungal infections.
Conference Coverage
Emerging invasive fungal infections call for multidisciplinary cooperation
“We need epidemiologists, doctors, and microbiologists to join ... to generate the necessary databases.”
Latest News
FDA approves oteseconazole for chronic yeast infections
It is the first FDA-approved product for the treatment of recurrent vulvovaginal candidiasis.
From the Journals
COVID-19–associated ocular mucormycosis outbreak case study reveals high-risk group for deadly complication
“The mortality indicators we observed ... can help physicians triage patients for emergency procedures.”
Conference Coverage
Fungal infection can mimic lung cancer metastases
Conference Coverage
Oteseconazole promising for recurrent yeast infections
Oteseconazole was superior to fluconazole/placebo in the proportion of subjects with at least one culture-verified acute vulvovaginal candidiasis...
From the Journals
Candida auris transmission can be contained in postacute care settings
A new study from Orange County, California, shows how Candida auris, an emerging pathogen, was successfully identified and contained in...
News from the FDA/CDC
Untreatable, drug-resistant fungus found in Texas and Washington, D.C.
From the Journals
Fungemia, other fungal infections associated with s. Boulardii probiotics